Filter Search for grants
Program navigation
Program key data
Horizon Europe - Cluster 1 - Destination 3: Tackling diseases and reducing disease burden
Parent program | Horizon Europe |
Link to the program | ec.europa.eu |
Content of program
short description | Cluster 1 "Health" of the Horizon Europe programme includes many topics from the field of health research. Projects cover the entire spectrum of the research and innovation cycle as far as possible and should also contribute to the implementation of research results in health care. Destination 3 will focus on major societal challenges linked to the Commission’s political priorities such as the fight against cancer and other non-communicable diseases, better diagnosis and treatment of rare diseases, preparedness and response to and surveillance of health threats and epidemics, reduction of the number of antimicrobial-resistant infections, improving vaccination rates, demographic change, mental health and digital empowerment in health literacy. |
program objectives | The aims of this cluster include improving and protecting the health and well-being of citizens of all ages by generating new knowledge, developing innovative solutions and integrating where relevant a gender perspective to prevent, diagnose, monitor, treat and cure diseases. Further aims include developing health technologies, mitigating health risks, protecting populations and promoting good health and well-being in general and at work. Finally, this cluster also aims to make public health systems more cost-effective, equitable and sustainable, prevent and tackle poverty-related diseases and support and enable patients' participation and self-management. Areas of intervention
read more |
Expected effects and impacts | Proposals for topics under this destination should set out a credible pathway to contributing to tackling diseases and reducing disease burden, and more specifically to several of the following impacts:
The EU benefits from high visibility, leadership and standing in international fora on global health and global health security, especially in partnership with Africa. read more |
Regions / countries for funding | EU Member States, Overseas Countries and Territories (OCT) Moldova (Moldova), Albania (Shqipëria), Armenia (Հայաստան), Azerbaijan (Azərbaycan), Belarus (Беларусь), Bosnia and Herzegovina (Bosna i Hercegovina / Босна и Херцеговина), Faeroes (Føroyar / Færøerne), Georgia (საქართველო), Iceland (Ísland), Israel (ישראל / إِسْرَائِيل), Kosovo (Kosova/Kosovë / Косово), Montenegro (Црна Гора), Morocco (المغرب), New Zealand (Aotearoa), North Macedonia (Северна Македонија), Norway (Norge), Serbia (Srbija/Сpбија), Tunisia (تونس /Tūnis), Türkiye, Ukraine (Україна), United Kingdom |
eligible entities Partners |
Research Institution incl. University, Private institution, incl. private company (private for profit), Small and medium-sized enterprise (SME), Public Body (national, regional and local; incl. EGTCs), Education and training institution, Other, Non-Profit Organisation (NPO) / Non-Governmental Organisation (NGO), International organization |
Mandatory partnership | Yes |
Project Partnership | To be eligible for funding, applicants must be established in one of the following countries:
Only legal entities forming a consortium are eligible to participate in actions provided that the consortium includes, as beneficiaries, three legal entities independent from each other and each established in a different country as follows:
Any legal entity, regardless of its place of establishment, including legal entities from non-associated third countries or international organisations (including international European research organisations) is eligible to participate (whether it is eligible for funding or not), provided that the conditions laid down in the Horizon Europe Regulation have been met, along with any other conditions laid down in the specific call topic. A ‘legal entity’ means any natural or legal person created and recognised as such under national law, EU law or international law, which has legal personality and which may, acting in its own name, exercise rights and be subject to obligations, or an entity without legal personality. Specific cases:
|
Additional information
Topics | Administration & Governance, Institutional Capacity & Cooperation, Demographic Change, European Citizenship, Migration, Digitalisation, Digital Society, ICT, Equal Rights, Human Rights, People with Disabilities, Social Inclusion, Health, Social Services, Sports |
Relevance for EU Macro-Region | EUSAIR - EU Strategy for the Adriatic and Ionian Region, EUSALP - EU Strategy for the Alpine Space, EUSBSR - EU Strategy for the Baltic Sea Region, EUSDR - EU Strategy for the Danube Region |
UN Sustainable Development Goals (UN-SDGs) | |
Program documents | HE-Work Programme 2023-2024, Cluster 1, Destination 3 (557kB) |
Contact | National Contact Points for Horizon Europe Website |
Open calls
26.04.2023 - 19.09.2023
European Partnership on Rare Diseases
12.01.2023 - 19.09.2023
European Partnership: One Health Anti-Microbial Resistance
26.10.2023 - 11.04.2024
European partnership for pandemic preparedness
25.04.2024 - 26.11.2024
Implementation research for management of multiple long-term conditions in the context of non-communicable diseases (Global Alliance for Chronic Diseases - GACD)
25.04.2024 - 26.11.2024
Interventions in city environments to reduce risk of non-communicable disease (Global Alliance for Chronic Diseases - GACD)
12.01.2023 - 13.04.2023
Novel approaches for palliative and end-of-life care for non-cancer patients
12.01.2023 - 13.04.2023
Pandemic preparedness and response: Adaptive platform trials for pandemic preparedness
26.04.2023 - 19.09.2023
Pandemic preparedness and response: Broad spectrum anti-viral therapeutics for infectious diseases with epidemic potential
12.01.2023 - 13.04.2023
Pandemic preparedness and response: Host-pathogen interactions of infectious diseases with epidemic potential
26.10.2023 - 11.04.2024
Pandemic preparedness and response: Immunogenicity of viral proteins of viruses with epidemic and pandemic potential
12.01.2023 - 13.04.2023
Pandemic preparedness and response: Maintaining and enhancing the preparatory work for a co-funded European partnership for pandemic preparedness
25.04.2024 - 30.05.2024
Pandemic preparedness and response: Maintaining the European partnership for pandemic preparedness
26.10.2023 - 11.04.2024
Pandemic preparedness and response: Sustaining established coordination mechanisms for European adaptive platform trials and/or for cohort networks
12.01.2023 - 13.04.2023
Pandemic preparedness and response: Understanding vaccine induced-immunity
12.01.2023 - 13.04.2023
Relationship between infections and non-communicable diseases
12.01.2023 - 13.04.2023
Tackling high-burden for patients, under-researched medical conditions
26.04.2023 - 19.09.2023
Towards structuring brain health research in Europe
12.01.2023 - 13.04.2023
Validation of fluid-derived biomarkers for the prediction and prevention of brain disorders
26.04.2023 - 19.09.2023